Finance

Lists
Why is 688575 down 2.13%?
Dive Deeper
688575:SHA
Shenzhen YHLO Biotech Co Ltd
CNÂ¥10.12
-2.13%
(-0.22) 1D
Oct 14, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688575...
Open
CNÂ¥10.27
High
CNÂ¥10.28
Low
CNÂ¥10.08
Mkt. cap
5.91B
Avg. vol.
12.11M
Volume
6.25M
Dividend
0.21%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 12, 2026
P/E ratio
78.05
52-wk high
CNÂ¥17.00
52-wk low
CNÂ¥8.34
EPS
CNÂ¥0.13
No. of employees
2K
Open
CNÂ¥10.27
High
CNÂ¥10.28
Low
CNÂ¥10.08
Mkt. cap
5.91B
Avg. vol.
12.11M
Volume
6.25M
Dividend
0.21%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 12, 2026
P/E ratio
78.05
52-wk high
CNÂ¥17.00
52-wk low
CNÂ¥8.34
EPS
CNÂ¥0.13
No. of employees
2K
News stories
From web sources and news partners
About Shenzhen YHLO Biotech Co Ltd
CEO-
Employees1.69K
FoundedSep 17, 2008
Headquarters-
SectorMedical device
Websiteszyhlo.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
478.27M
523.91M
397.82M
490.14M
Cost of goods sold
186.62M
161.40M
150.01M
201.54M
Cost of revenue
186.62M
161.40M
150.01M
201.54M
Research and development expenses
67.33M
93.33M
65.92M
68.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
140.88M
215.15M
145.91M
150.08M
Operating expense
203.67M
331.34M
204.45M
231.02M
Total operating expenses
390.29M
492.74M
354.45M
432.56M
Operating income
87.98M
31.18M
43.37M
57.58M
Other non operating income
-2.05M
-191.51K
-16.80M
16.10M
EBT including unusual items
41.55M
30.00M
17.84M
57.13M
EBT excluding unusual items
81.94M
22.04M
23.76M
60.42M
Income tax expense
10.82M
16.58M
117.28K
3.23M
Effective tax rate
26.03%
55.28%
0.66%
5.66%
Other operating expenses
-7.49M
18.27M
-4.44M
10.02M
Net income
34.15M
-37.08M
17.95M
52.18M
Net profit margin
7.14%
-7.08%
4.51%
10.65%
Earnings per share
-
-
-
-
Interest and investment income
1.22M
2.36M
1.60M
1.97M
Interest expense
-3.99M
-8.29M
-4.41M
-6.44M
Net interest expenses
-2.77M
-5.94M
-2.80M
-4.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
147.85M
102.18M
114.37M
133.25M
Gain or loss from assets sale
-1.14M
336.41K
-
254.58K
AI content may include mistakes. Learn more
Google apps